Maxolon High Dose

Metoclopramide, the active ingredient in Maxolon High Dose, is a dopamine antagonist presented as an intravenous injection for use in the treatment of nausea, vomiting and gastroparesis in adult patients. It works by blocking dopamine receptors in the chemoreceptor trigger zone and enhancing gastrointestinal motility.

GNH USA supplies Maxolon High Dose as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Metoclopramide is employed to manage conditions that involve nausea, vomiting or delayed gastric emptying. - Nausea and vomiting: reduces the frequency and severity of acute and chronic episodes. - Gastroparesis: improves gastric emptying and alleviates related symptoms. - Postoperative nausea and vomiting: prevents and treats nausea after surgical procedures.

Metoclopramide may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Drowsiness: feeling unusually sleepy or fatigued. - Restlessness: a sense of inner tension or inability to stay still. - Diarrhea: increased frequency of loose stools. - Dry mouth: reduced salivation leading to a parched feeling. - Headache: mild to moderate head pain.

Serious or Rare Side Effects: - Extrapyramidal symptoms: involuntary muscle movements or rigidity. - Tardive dyskinesia: persistent, irreversible facial or tongue movements. - Neuroleptic malignant syndrome: high fever, muscle rigidity, autonomic instability. - Severe allergic reaction: rash, itching, swelling, or breathing difficulty.

When using Metoclopramide, clinicians should consider several safety measures. - Assess renal and hepatic function: adjust use in impairment. - Monitor for signs of extrapyramidal reactions: especially in the elderly. - Evaluate for depression or suicidal thoughts: dopamine antagonism may affect mood. - Use caution in patients with seizure disorders: may lower seizure threshold. - Store below 25°C: keep in the original container, protect from light and moisture.

Metoclopramide can interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid): - Anticholinergic agents: may reduce pro‑kinetic effect. - MAO inhibitors: increase risk of hypertensive crisis. - CNS depressants (e.g., opioids, benzodiazepines): enhance sedation and respiratory depression.

Moderate Interactions (Monitor Closely): - CYP2D6 substrates (e.g., codeine, tramadol): may increase plasma levels. - Antihistamines: can potentiate drowsiness. - Digoxin: may increase serum concentrations.